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Abstract
Bone loss continues to be a concern in spaceﬂight, with some crew members
depicting local losses of up to 25% within a 6-month mission. Possible causes
are direct or indirect effects by microgravity, radiation, dietary restriction, and
atmospheric challenges. Despite their magnitude, bone losses have not yet led
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to increased fracture rates in astronauts returning from low-Earth orbit (LEO)
missions. This could change for deep space missions, in particular to planets
where falls and trauma will occur. Physical countermeasures, meant to provide
musculoskeletal loading forces in the body’s lower half, are an important
contribution to crew bone health. This requirement becomes an increasing imper-
ative with prolonged missions. Forces and moments transmitted from exercise
devices should therefore be considered at an early stage of the planning of space
habitats. In addition, appropriate shielding against ionizing radiation, avoidance
of exaggerated accumulation of CO2, and provision of a balanced diet will all
contribute to bone health in astronaut crews.
Glossary
Bone health The well-being of our bones, including the
cellular, endocrine, structural, and materials-
mechanical well-being
Bone loss Reduction in bone tissue abundance; resulting
from an imbalance between bone tissue formation
and bone tissue resorption; leading to reduced
strength, thereby increasing the risk of fracture
Caloric restriction Reduced dietary energy supply
Collagen One of the most abundant proteins in our body.
It transfers tensile strength and stiffness
D-hormone A hormone from the parathyroideal gland that is
involved in the nomeostasis of calcium and
phosphorus; also known as 1,25-hydroxy-vitamin
D
Fracture Physical bone damage that involves pathological
discontinuity of the bone; typically caused by
trauma
Hypercapnia Retention and accumulation of carbon dioxide
within the body
Hypogravity Any gravitational ﬁeld with less gravity than
present on the Earth
Hypoxia Any atmosphere with oxygen partial pressure
< 20 kPa
Material fatigue Weakening of material by repeatedly occurring
strains
Mechanostat A concept that explains how bones can adapt their
structure to variant forces
Mechanotransduction Transformation of mechanical information (e.g.,
material strain) into biological information (i.e.,
molecular signals)
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Metabolism The set of chemical reactions that supports life
Microgravity In a strict sense, the virtual absence of gravity;
however, the term is also often used to describe
an environment that provides only very little accel-
eration, e.g., on orbital space vehicle trajectories
Musculoskeletal loading force The bulk of all forces that occur in muscles, bones,
tendons, etc. during habitual activities; these forces
in our body are typically much greater than forces
that our body can transfer onto its environment
Osteoblast A type of bone cell that forms bone tissue
Osteoclast A type of bone cell that degrades and resorbs bone
tissue
Osteocyte A type of bone cell that resides within the hard
bone tissue; thought to be involved in mechano-
transductcion and in electrolyte homeostasis
Parathyroid hormone A hormone from the parathyroideal gland that is
involved in the nomeostasis of calcium and
phosphorus
Physical exercise Muscular contractions that generate force and
challenge the body’s energy metabolism;
performed with the idea to enhance one’s well-
being or one’s physical capacity
RANKL Receptor activator of NF-kappa B receptor
Renal excretion Clearance from the body’s milieu by the kidneys
and excretion via the piss
Renal stone A concrement that has built up on the deriving
urinary tract from urinary compounds
Strain The dimensionless deformation of material; the
material’s stress causes material strain; the integral
of material strain is the source of the material’s
reactive force
Trauma Physical challenge (e.g., fall) that leads to tissue
damage within the body
Vitamin D A vitamin that is metabolized by ﬁrst the liver and
then the kidney to the D-hormone
Introduction
In bone tissue, a relatively small number of cells live in and on an extensive
extracellular matrix. The crystalline mineral phase of that matrix provides
compressive stiffness and strength, and its protein constituent adds tensile and
shear stiffness and strength. Bone matrix is an outstanding material in combining
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great stiffness, strength, and toughness. Bone stiffness is the prerequisite for the
body’s movement system (i.e., muscles, tendons, and fascia) to transfer moments
and forces. Weakening of the skeletal basis leads to fractures, pain, and loss of
mobility. Bone health therefore deserves consideration in long-term space missions,
where bone losses are known to be endemic.
The Physiological Basis of Bone Health
Bone Matrix
The bone matrix is composed from an organic and an inorganic phase. The organic
phase, also called the protein phase, consists predominantly of type-1 collagen
(90–95%). Type-1 collagen is a ﬁbrillary protein. Two α1 and one α2 procollagen
strands assemble into 300-nm-long ﬁbers that in essence exploit the tensile strength
of the amidic bond. Speciﬁc cross-linking proteins strengthen and toughen
the collagen strands orthogonally to their ﬁbril orientation. Other constituents of
the organic matrix, besides collagen, are proteoglycans, carboxylated osteocalcin,
osteopontin, and TGF-β. Likely, their role is not primarily mechanical but rather
endocrine and regulatory (discussed for TGF-β and osteocalcin below).
The mineral phase consists mostly of calcium and phosphate, with smaller
fractions of sodium, magnesium, and other minerals. The largest part of these
minerals is organized in crystalline structure, located as spheroids or plates within
speciﬁc niches between collagen strands. A smaller fraction of minerals can also
be found in noncrystalline state, also called amorphous mineral. That fraction is
mostly found around osteocytes and their processes (see next paragraph). The
mineral phase adds compressive and shear strength to the protein phase’s tensile
strength. Proteins, such as osteopontin, facilitate crystallization of bone minerals.
Genetic aberrations of the collagen-1 gene in osteogenesis imperfecta (brittle bone
disease) are thought to alter the crystallization niche and thereby the bone matrix’
material properties.
Bone Cells
As with all biological material, bone matrix is the product of cellular activity.
Osteoblasts reside on surfaces and produce bone protein, which is also called osteoid
(see Fig. 1). In a second step, osteoblasts also help to mineralize the protein phase.
While bone matrix is accrued onto existing surfaces, some osteoblasts embed
themselves into the matrix and transform into osteocytes. These osteocytes entertain
physical links with osteoblasts and with their neighboring osteocytes via cellular
processes. That way, the osteoblast-osteocyte network can exchange ions and small
molecules. When bone formation drifts cease, osteocytes become gradually
ﬂatter and eventually dormant. They are then called lining cells. Their function
is to separate the bone matrix (with high calcium-phosphorus product) from the
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interstitial and blood ﬂuids (with low calcium-phosphorus product (Marenzana
et al. 2005)). Importantly, lining cells can develop back into osteoblasts, but osteo-
cytes cannot. Recent evidence suggests that osteoblasts, via secretion of under-
carboxylated osteocalcin, may also be involved in the body’s energy metabolism.
The fourth type of bone cells is the osteoclast, which breaks down and resorbs
bone matrix. Osteoclasts derive from macrophages, i.e., blood-borne inﬂammatory
cells. They thus differ fundamentally from the mesenchymal lineage of osteoblasts/
osteocytes/lining cells. In order to resorb bone, osteoclasts seal the surface beneath
them, dissolve the crystal phase by acidiﬁcation to pH 4.5, and degrade the protein
phase with cathepsin K and other digestive enzymes (Teitelbaum 2000).
Bone Tissue Organization
Bones are covered by cartilage where they transmit transsegmental compressive
forces. The rest of their outer surfaces is clad by periosteum, a connective tissue rich
in vessels, nerve ﬁbers, and pain receptors. Beneath cartilage and periosteum lies the
bone cortex. Its thickness ranges from hundreds of μm in proximity of joints to tens
of mm in the middle of long shafts (see Fig. 2). The tissue organization can be either
compact, where no marrow tissue is interspersed, or spongy, where a network of
mechanically linked bone struts lies within the bone marrow.
Fig. 1 Human trabecular bone from an iliac crest biopsy in an 8-year-old boy. Note that the bone
surface on the upper trabeculum (covered with osteoid) is smooth but scalloped on the lower
trabeculum. This is because the latter had previously undergone resorption, whereby osteoclasts
leave their “bite marks.” Orchestrated formation-resorption drifts on opposing sides are typical of
modeling and lead to structural adaptation of bones
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Regulation of Bone Cell Activity
Bone tissue responds to mechanical stimuli. Popular theories of bone adaptation,
such as the mechanostat theory (Frost 1987) suggest that bone gains and bone losses
are positively and negatively, respectively, affected by bone tissue strains (Fig. 3).
The idea thus is that of a negative feedback loop, with bone tissue strains as the
invariant that adapts bone size and structure to match the mechanical requirements.
Originally, strains in the order of 103 were proposed as a threshold. However,
substantially greater strains are occurring in vivo (Yang et al. 2011), suggesting that
this threshold may be much higher. Although the exact mechanisms are not fully
understood, osteocytes are thought to biologically sense the bone tissue strains
(Bonewald 2006). They control osteoblastic activity via sclerostin, and the
Fig. 2 Anatomical makeup
of a human metatarsal. Joint
surfaces (top and bottom), as
well as the mid-shaft, are
composed of relatively thick,
compact bone layers.
Trabecular struts, which
distribute forces from the shaft
toward the joints, are much
thinner
Fig. 3 Mechanostat theory. Alterations in habitual bone strains engender alterations in formation
and resorption. The bone balance is given by formation minus resorption. Positive bone balance
leads to stiffer and stronger bone structures, thereby reducing strains. Thus, the mechanostat theory
explains how invariance of bone strains helps to adapt bone structures to variable habitual forces
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osteoblasts in turn control osteoclasts via RANKL. Thus, the initial
mechanotransduction step gets translated into a biochemically orchestrated response
of both osteoblasts and osteoclasts. Bone accrual in response to exaggerated force
exposure has been described as “modeling.”Here, bone formation and resorption are
simultaneously taking place at opposing surfaces, thus causing drifts within a bone’s
geometrical shape (see Fig. 1).
It is important to understand that the largest forces in our body’s movement
system do not emerge from gravity per se but rather from the interaction of muscle
contractions with mass inertial forces (see Fig. 4). Muscular forces therefore are an
important constituent of bone’s mechanical adaptation. Moreover, impact loading of
bone seems particularly effective to build strong bones (Nikander et al. 2005). This is
both because strain rate, in addition to strain magnitude, induces bone gains (Mosley
and Lanyon 1998) and also because muscles generate greatest forces when they are
stretched while actively contracting (Westing et al. 1988).
In contrast to modeling, the “remodeling” mode serves for tissue renewal, thus
helping to prevent material fatigue. Here, the bone is ﬁrst resorbed in a given place,
and the cavity is subsequently ﬁlled up by osteoblastic formation. Importantly, when
Fig. 4 Moments and forces around the ankle joint. The calf muscles work against a lever of 1:3.
Thus, when standing or hopping on the ball of the foot, calf muscle forces exceed the ground
reaction force (FGR) by a factor of 3. In addition, inertial forces of the body’s mass (Fm.a) engender
approximately another times the ground reaction force, so that loading of the tibia in this scenario is
four times greater than ground reaction forces. Thereby, a ground reaction force of 2500 N during
one-legged vertical hopping leads to a tibia force of 10,000 N, equivalent to 1 ton. Generally, all our
muscles work against short levers, ranging from 1:2 to 1:10
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tissue strains remain too low, then the re-ﬁlling of the cavity becomes incomplete,
leading to net bone losses. TGF-β deliberated from the bone matrix stimulates
proliferation of osteoblasts, thus closing the information linked from osteoclasts to
osteoblasts (Bonewald and Mundy 1990). Moreover, the reversal between resorption
and formation during the remodeling cycle creates a seam between old and new bone
that is microscopically visible as the so-called reversal line. This line constitutes a
mechanical discontinuity that helps to prevent propagation of microcracks. It is thus
important for the toughness of the bone matrix.
Metabolic and Endocrine Aspects of Bone
Of the 1 kg of calcium in our body, 999 g is within the bone. Notably, calcium
is an important signal in most cells, and its extracellular concentration is therefore
regulated within narrow limits. Calcium trafﬁcking within the body is therefore
critical and tricky. These constraints dictate that bone adaptation cannot be a quick
process. Constraints for phosphate trafﬁcking are less harsh, which is why distur-
bances of calcium metabolism are clinically more frequent. The trafﬁcking of
calcium and phosphorus is jointly regulated in the human body by parathyroid
hormone (PTH), the D-hormone, which is metabolized from vitamin D (VitD),
and ﬁbroblast growth factor 23 (FGF23). The main actions of PTH are enhancing
renal and intestinal calcium absorption, stimulating calcium extraction from bone,
enhancing renal phosphorus excretion, and activating VitD to the D-hormone.
D-hormone promotes intestinal absorption of calcium and phosphate, and it sup-
presses production of PTH in the parathyroid gland but enhances production
of FGF23 by osteocytes. Compared to PTH, the effects of VitD are much slower.
FGF23 induces renal phosphorus excretion, and it suppresses activation of VitD to
the D-hormone. During periods of bone loss, serum calcium levels are virtually
unchanged, owed to reduced expression of PTH and thus to reduced intestinal uptake
and renal excretion. However, this is at the risk of renal stone formation in bed rest
(Watanabe et al. 2004) and spaceﬂight (Jones et al. 2008).
Recent research suggests that constituents of the protein phase may also impact
on organismic metabolism. Thus, osteocalcin, which is deliberated into the blood
during bone resorption, enhances insulin production, cognitive functioning, and
muscular fuel utilization (Lee et al. 2007). TGF-β is not only a stimulator for
osteoblasts; it also seems to negatively affect calcium handling within skeletal
muscle and thereby its contractions (Regan et al. 2017). Future research needs to
expand our understanding of such nonmechanical muscle-bone interactions.
Microgravity
Elevated urinary calcium excretion was the ﬁrst hallmark of microgravity-related
bone loss during Skylab (Vogel and Whittle 1976) before structural post-ﬂight
bone deﬁcits were demonstrated (Schneider et al. 1992). Bone losses amount to
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1–2% per month on average from the legs and lower spine but do not occur in the
arms. Anecdotal, seemingly paradoxical evidence suggests small gains in the skull.
Bone losses vary greatly between individual crew members, with some losing up
to 25% of their distal tibia’s mass within a 6-month mission (Vico et al. 2000).
Importantly, space-related bone losses are driven both by increases in osteoclastic
bone resorption and by reduced bone formation, although the former seems more
pronounced than the latter (Caillot-Augusseau et al. 1998). Confronting the rapidity
of bone loss in space with the fact that yearly bone losses of 1% in vertebra
of postmenopausal women are associated with a fracture incidence of 1% per year
is cause for concern about the crew’s bone health in long-term missions. Luckily,
post-ﬂight bone losses seem to recover in astronauts (Lang et al. 2006), and there
is currently no evidence for increased fracture rates in astronauts. Thus, the theoret-
ical concern of bone health may be more relevant for missions to Moon and Mars,
i.e., mission scenarios where sojourns in microgravity are prolonged and where falls
and trauma may occur in hypogravity. In addition, bone losses put a risk to crew
health by enhancing the likelihood for renal stone formation (Jones et al. 2008).
As to the mechanisms, microgravity could affect bone cells (a) directly via
cellular gravi-sensation, (b) indirectly via canceling the body’s z-axis exposure to
the static gravity vector, or (c) indirectly by “idling” the human body. While the
existence of direct gravity effects on bone cell precursors has been qualitatively
demonstrated in vitro (Cazzaniga et al. 2016), the quantitative relevance of these
effects in vivo is yet to establish. Although some extreme experimentations suggest
a role for hydrostatic ﬂuid pressures for bone maintenance, there is overall only
speckled evidence for the static gravity vector’s importance to the bone. By contrast,
a huge body of evidence suggests that preventing effective force generation readily
induces bone losses even when people are exposed and aligned to the gravity vector
(Rittweger et al. 2006b). Foot forces and thus musculoskeletal forces in the lower
body half are low during habitual activity on board the international space station
(ISS) (Cavanagh et al. 2010), as well as during countermeasure exercises (De Witt
and Ploutz-Snyder 2014). This and the fact that bone losses in experimental bed
rest can quantitatively compare with those induced by spaceﬂight (Pavy-Le Traon
et al. 2007) suggest that idling of the body’s movement system is indeed a powerful
driver of spaceﬂight-induced bone losses. Accordingly, physical exercise to replace
the bone loading can be identiﬁed as an important strategy to maintain crew bone
health.
Ionizing Radiation
Space travelers are exposed to ionizing radiation levels that are substantially higher
than on Earth. The source is galactic cosmic radiation and intermittently also
radiation from solar particle events. It has been long known that cumulative radiation
doses in excess of 40 Gy, as in cancer treatment, can induce necrosis of bone
(Felsenberg and Armbrecht 2012), i.e., non-programmed cell death of bone cells
and subsequent degradation of tissue. Equivalent doses for bone on board the ISS are
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around 0.6 mSv per day. Thus, for a 1-year mission, the expected radiation dose for
bone is two orders of magnitude below the threshold for necrosis but also two orders
of magnitude above doses on Earth. In mice, a cumulated dose of 2 Gy decreases
osteoblastic activity while increasing osteoclastic activity (Willey et al. 2008). The
combined effect is bone loss and deterioration of bone architecture (Kondo et al.
2009). Moreover, bone loss and fractures are risks ensuing from irradiation therapy
in cancer patients (Baxter et al. 2005). Shielding space habitats against ionizing
radiation is therefore not only important from a perspective of cancer prevention but
also with respect to bone health.
Atmospheric Conditioning
Atmospheric conditioning on ISS is similar to sea levels on Earth, i.e., a total
pressure of 100 kPa, 21% of which is made up by O2 and the rest by N2.
The requirement for frequent extravehicular activity (EVA) might change in future
lunar and Martian habitats, as lowered N2 partial pressure (PN2) would reduce the
risk of decompression sickness. Simultaneously, PO2 would have to be reduced
for ﬁre hazard reasons. This must be expected to cause a risk, as cellular studies
suggest that hypoxia reduces osteoblastic functioning and increases osteoclastic
activity (Arnett 2010). More supporting evidence for detrimental effects of hypoxia
comes from studies that report deteriorated bone health in patients with chronic
obstructive pulmonary disease (Shane et al. 1996) and sleep apnea (Tomiyama et al.
2008). However, PO2 lowered to an equivalent altitude of 4000 m had no sizeable
effects on bone turnover in healthy young men (Rittweger et al. 2016). There is thus
little evidence to suggest a bone health issue for hypoxic planetary stations, in
particular when the hypoxia is equivalent to ~1500 m as currently planned. The
third gas that needs to be mentioned is carbon dioxide (CO2). Accumulation of CO2
in the body, also called hypercapnia, leads to acidosis. Acidosis in turn negatively
affects bone metabolism in cellular studies (Arnett 2010). Unfortunately, there have
been no human studies yet to investigate possible effects of hypercapnia on bone
health.
Diet
The idea that a healthy diet is important for bone is widely shared, but it is not
understood in detail what deﬁnes a bone-healthy diet during spaceﬂight. The current
recommended dietary intake of VitD for astronauts is 800 international units per day,
which coincides with the recommendation for adults on Earth by the World Health
Organization. Bearing in mind that astronauts are not exposed to sunlight, their
serum VitD levels will be somewhat lower than in people on Earth. However,
enhancing serum VitD levels in astronauts could exaggerate the risk of renal stone
formation. This is because VitD not only enhances intestinal calcium absorption but
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also renal calcium excretion. Ongoing bone loss, as in spaceﬂight, by itself increases
renal calcium and phosphate excretion and can thereby cause renal stone formation.
Caloric restriction (Berrigan et al. 2005) and protein restriction (Ammann et al.
2000) both lead to bone losses in animal studies. Dietary enrichment with animal
protein, however, leads to acidiﬁcation of the internal milieu, with potentially
negative effects on bone health. Finally, NaCl deserves attention, as it can potentiate
immobilization-induced bone losses (Frings-Meuthen et al. 2011). Possible mecha-
nisms are a low-grade metabolic acidosis (Frings-Meuthen et al. 2008) or induction
of macrophage-derived immune responses (Kleinewietfeld et al. 2013). In summary,
a eucaloric diet with a balanced animal and plant protein contribution and with
somewhat reduced intakes of VitD and NaCl seems reasonable for a bone-healthy
space diet.
Countermeasure Exercises
Current countermeasure exercises on ISS consist in treadmills, in resistive exercise
devices, and in cycle ergometers. These countermeasures have become increasingly
effective in preventing bone losses (LeBlanc et al. 2000; Smith et al. 2014).
However, there still is sizable bone loss from the lower leg after astronauts return
to Earth (unpublished data from our lab). Numerous other countermeasures have
been tested with the ground-based analog of experimental bed rest. In these studies,
two approaches have proved particularly powerful, namely, resistive vibration exer-
cise (RVE) (Rittweger et al. 2000) and reactive jump training (RJT) (Kramer et al.
2017). Notably, both approaches constitute a type of impact exercise, which is
believed to be most effective for building strong bones. Given the crucial role that
muscles play for bone health, training programs in space should target all elements
of the musculoskeletal system, namely, muscle, bone, tendon, and other passive
connective tissue. Resistance exercises, or indeed impact exercises like RVE and
RJT, are more apt for this than treadmill or bicycle exercise. When RVE and RJT
are performed in highly intense, short bouts, then they share many similarities with
high-intensity interval training (HIIT), which may explain why they also have
demonstrated some effectiveness for the cardiovascular system (Rittweger et al.
2006a; Kramer et al. 2017). As to the frequency of exercise sessions, astronauts on
ISS are currently training 6–7 times per week. This practice is supported by evidence
from bed-rest studies, where countermeasures become ineffective when they are
performed only 3 times per week or less. Finally, human centrifugation, also called
artiﬁcial gravity (AG) in the context of space studies, should be considered as
a holistic countermeasure that can potentially alleviate any microgravity-related
problem (Artiﬁcial Gravity 2007). However, research is still undetermined as to
how to best utilize AG.
Maintaining Crew Bone Health 11
Pharmacological Strategies
There is a wide range of drugs available for prevention of bone loss. Pharmacolog-
ical prevention of bone losses therefore needs to be considered for future missions, in
particular for deep space missions where radiation will engender additional risks for
bone health. Alendronate, a bone anti-resorptive drug of the ﬁrst generation, has
already achieved substantial suppression of bone losses in space (LeBlanc et al.
2002). Unfortunately, gastrointestinal side effects (reﬂux) preclude it from further
consideration, but several other drugs can be considered for future long-term
missions.
Trauma and Fractures
Osteoporotic vertebral fractures typically occur without a fall. For all other fractures,
there is typically a fall or trauma preceding the fracture. The limited evidence that
is available on fracture healing in space suggest that microgravity may hinder
fracture healing (Kaplansky et al. 1990). Fracture prevention therefore deserves
consideration. While falls are impossible in microgravity, trauma may still occur.
For example, crew members might trap their ﬁngers or arms in slings or handles
when ﬂoating fast through the habitat. On planetary stations, falls will occur.
Banisters and hand rails will therefore be required. Their heights need to be as on
Earth (dictated by the body’s center of mass’ elevation), but the safety margins
relating to falling height can be lowered in proportion to the gravity reduction.
Recommendations for the Design of Space Habitats
In summary, from a bone health perspective, the ﬁrst requirement for space habitats
is the provision of adequate countermeasure exercise facilities. Reactive jumps
and other forms of plyometric training will be straightforward for planetary habitats.
For ﬂying space vehicles a trade-off can be made between duration of ﬂight and
countermeasure effort. In other words, short missions that last only few weeks could
probably neglect the risk of bone losses (simply because of the slow response,
relative to other organs), but care should then be taken of the risk of renal stone
prevention. To accommodate exercise devices, space habitats need to tolerate forces,
impacts, and moments transferred from these exercise devices onto the habitat. This
is particularly crucial for AG, as the deceleration of a centrifuge has to occur very
fast during emergency egress.
Another requirement is the reduction of radiation exposure to levels that
are acceptable for bone health. Furthermore, it may be prudent to avoid exaggerated
accumulation of CO2 in the habitat’s atmosphere. Although only very limited
evidence is available on CO2 effects on human bone, levels of up to 0.5–1 kPa,
as currently on ISS, seem acceptable. A bone-healthy diet (described above) is a
prerequisite for bone health in space. Finally, the architectural design for planetary
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habitats needs to adapt gravitational constraints to adequately prevent falls and
fractures.
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